GUARDANT HEALTH, INC. Basic Shares Outstanding (Weighted Average)
GUARDANT HEALTH, INC. (GH) reported Basic Shares Outstanding (Weighted Average) of 132.87 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-30
- GUARDANT HEALTH, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 132.87M shares, a 7.05% increase year-over-year.
- GUARDANT HEALTH, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 131.27M shares, a 5.98% increase year-over-year.
- GUARDANT HEALTH, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 128.69M shares, a 3.98% increase year-over-year.
- GUARDANT HEALTH, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 124.81M shares, a 1.43% increase year-over-year.
- GUARDANT HEALTH, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 125.37M shares, a 2.14% increase from fiscal 2024.
- GUARDANT HEALTH, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 122.75M shares, a 9.61% increase from fiscal 2023.
- GUARDANT HEALTH, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 111.99M shares, a 9.60% increase from fiscal 2022.
- GUARDANT HEALTH, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 102.18M shares, a 0.85% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 132.87M shares 10-Q · filed 2026-07-30 | 132.07M shares 10-Q · filed 2026-07-30 | 130.94M shares derived: average of 3 quarters · filed 2026-07-30 | 129.41M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | 131.27M shares 10-Q · filed 2026-05-07 | 129.98M shares derived: average of 2 quarters · filed 2026-05-07 | 128.26M shares derived: average of 3 quarters · filed 2026-05-07 | 127.22M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | 128.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 126.75M shares derived: average of 2 quarters · filed 2026-02-19 | 125.87M shares derived: average of 3 quarters · filed 2026-07-30 | 125.37M shares 10-K · filed 2026-02-19 |
| 2025-09-30 | 124.81M shares 10-Q · filed 2025-10-29 | 124.46M shares derived: average of 2 quarters · filed 2026-07-30 | 124.27M shares 10-Q · filed 2025-10-29 | 124.14M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | 124.11M shares 10-Q · filed 2026-07-30 | 123.99M shares 10-Q · filed 2026-07-30 | 123.92M shares derived: average of 3 quarters · filed 2026-07-30 | 123.70M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | 123.87M shares 10-Q · filed 2026-05-07 | 123.82M shares derived: average of 2 quarters · filed 2026-05-07 | 123.56M shares derived: average of 3 quarters · filed 2026-05-07 | 123.28M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 123.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 123.41M shares derived: average of 2 quarters · filed 2026-02-19 | 123.09M shares derived: average of 3 quarters · filed 2026-02-19 | 122.75M shares 10-K · filed 2026-02-19 |
| 2024-09-30 | 123.05M shares 10-Q · filed 2025-10-29 | 122.75M shares derived: average of 2 quarters · filed 2025-10-29 | 122.41M shares 10-Q · filed 2025-10-29 | 121.45M shares derived: average of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | 122.45M shares 10-Q · filed 2025-07-30 | 122.08M shares 10-Q · filed 2025-07-30 | 120.91M shares derived: average of 3 quarters · filed 2026-02-19 | 120.12M shares derived: average of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | 121.71M shares 10-Q · filed 2025-04-30 | 120.15M shares derived: average of 2 quarters · filed 2026-02-19 | 119.34M shares derived: average of 3 quarters · filed 2026-02-19 | 116.71M shares derived: average of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | 118.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 118.16M shares derived: average of 2 quarters · filed 2026-02-19 | 115.04M shares derived: average of 3 quarters · filed 2026-02-19 | 111.99M shares 10-K · filed 2026-02-19 |
| 2023-09-30 | 117.74M shares 10-Q · filed 2024-11-06 | 113.27M shares derived: average of 2 quarters · filed 2024-11-06 | 109.79M shares 10-Q · filed 2024-11-06 | 107.93M shares derived: average of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | 108.81M shares 10-Q · filed 2024-08-07 | 105.75M shares 10-Q · filed 2024-08-07 | 104.66M shares derived: average of 3 quarters · filed 2025-02-20 | 104.07M shares derived: average of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | 102.66M shares 10-Q · filed 2024-05-09 | 102.59M shares derived: average of 2 quarters · filed 2025-02-20 | 102.49M shares derived: average of 3 quarters · filed 2025-02-20 | 102.38M shares derived: average of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | 102.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | 102.40M shares derived: average of 2 quarters · filed 2025-02-20 | 102.28M shares derived: average of 3 quarters · filed 2025-02-20 | 102.18M shares 10-K · filed 2025-02-20 |
| 2022-09-30 | 102.29M shares 10-Q · filed 2023-11-06 | 102.17M shares derived: average of 2 quarters · filed 2023-11-06 | 102.06M shares 10-Q · filed 2023-11-06 | 101.97M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | 102.05M shares 10-Q · filed 2023-08-03 | 101.95M shares 10-Q · filed 2023-08-03 | 101.87M shares derived: average of 3 quarters · filed 2024-02-22 | 101.76M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | 101.85M shares 10-Q · filed 2023-05-09 | 101.78M shares derived: average of 2 quarters · filed 2024-02-22 | 101.66M shares derived: average of 3 quarters · filed 2024-02-22 | 101.54M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | 101.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 101.56M shares derived: average of 2 quarters · filed 2024-02-22 | 101.43M shares derived: average of 3 quarters · filed 2024-02-22 | 101.31M shares 10-K · filed 2024-02-22 |
| 2021-09-30 | 101.42M shares 10-Q · filed 2022-11-03 | 101.30M shares derived: average of 2 quarters · filed 2022-11-03 | 101.18M shares 10-Q · filed 2022-11-03 | 100.90M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | 101.17M shares 10-Q · filed 2022-08-04 | 101.06M shares 10-Q · filed 2022-08-04 | 100.72M shares derived: average of 3 quarters · filed 2023-02-23 | 100.43M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | 100.95M shares 10-Q · filed 2022-05-05 | 100.50M shares derived: average of 2 quarters · filed 2023-02-23 | 100.18M shares derived: average of 3 quarters · filed 2023-02-23 | 99.14M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | 100.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 99.80M shares derived: average of 2 quarters · filed 2023-02-23 | 98.53M shares derived: average of 3 quarters · filed 2023-02-23 | 97.50M shares 10-K · filed 2023-02-23 |
| 2020-09-30 | 99.55M shares 10-Q · filed 2021-11-04 | 97.78M shares derived: average of 2 quarters · filed 2021-11-04 | 96.66M shares 10-Q · filed 2021-11-04 | |
| 2020-06-30 | 96.01M shares 10-Q · filed 2021-08-05 | 95.20M shares 10-Q · filed 2021-08-05 | ||
| 2019-12-31 | 90.60M shares 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |